BE737674A - - Google Patents

Info

Publication number
BE737674A
BE737674A BE737674DA BE737674A BE 737674 A BE737674 A BE 737674A BE 737674D A BE737674D A BE 737674DA BE 737674 A BE737674 A BE 737674A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE737674A publication Critical patent/BE737674A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
BE737674D 1968-09-02 1969-08-19 BE737674A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR164817A FR7736M (enExample) 1968-09-02 1968-09-02

Publications (1)

Publication Number Publication Date
BE737674A true BE737674A (enExample) 1970-02-02

Family

ID=8654167

Family Applications (1)

Application Number Title Priority Date Filing Date
BE737674D BE737674A (enExample) 1968-09-02 1969-08-19

Country Status (5)

Country Link
BE (1) BE737674A (enExample)
DE (1) DE1944121A1 (enExample)
ES (1) ES371093A1 (enExample)
FR (1) FR7736M (enExample)
GB (1) GB1247306A (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
WO2005019179A2 (en) 2003-06-17 2005-03-03 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
NZ578503A (en) 2003-06-17 2011-02-25 Arena Pharm Inc Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
WO2006069363A2 (en) 2004-12-21 2006-06-29 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
DK1833473T3 (da) 2004-12-23 2010-01-11 Arena Pharm Inc 5HT2C-Receptormodulator-sammensætninger og metoder for anvendelse
EP2001852A2 (en) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
EP2099743B1 (en) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
KR20140091458A (ko) 2010-09-01 2014-07-21 아레나 파마슈티칼스, 인크. 신장 손상을 갖는 개체에 대한 로카세린의 투여
CA2808909A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
CN107669687A (zh) 2010-09-01 2018-02-09 艾尼纳制药公司 用于体重控制的5‑ht2c激动剂的调节释放剂型
JP2015534563A (ja) 2012-10-09 2015-12-03 アリーナ ファーマシューティカルズ, インコーポレイテッド 体重管理の方法

Also Published As

Publication number Publication date
DE1944121A1 (de) 1970-03-19
ES371093A1 (es) 1971-08-16
GB1247306A (en) 1971-09-22
FR7736M (enExample) 1970-03-09

Similar Documents

Publication Publication Date Title
AU1946070A (enExample)
AU2374870A (enExample)
FR7736M (enExample)
AU429879B2 (enExample)
AU416157B2 (enExample)
AU2581067A (enExample)
AU421558B1 (enExample)
AR203075Q (enExample)
AU2580267A (enExample)
AU3789668A (enExample)
AU3224368A (enExample)
BE709479A (enExample)
BE727785A (enExample)
BE727146A (enExample)
BE726540A (enExample)
BE726503A (enExample)
BE726476A (enExample)
BE725028A (enExample)
BE723360A (enExample)
BE718599A (enExample)
BE713344A (enExample)
BE709496A (enExample)
BE709484A (enExample)
BE727463A (enExample)
BE709446A (enExample)